Recombinant Human Kallikrein-7 Protein，GST

Kallikrein-7 (KLK7) is a member of the kallikrein family of serine proteases, which play a crucial role in various physiological processes, including skin homeostasis, inflammation, and tissue remodeling. KLK7 is predominantly expressed in the skin and is implicated in the degradation of keratin, a key structural protein in the epidermis. Research has demonstrated that altered expression of KLK7 is associated with several dermatological conditions, including psoriasis, dermatitis, and skin cancer. The interest in KLK7 as a therapeutic target has grown, particularly due to its potential role in mediating inflammatory responses and promoting keratinocyte proliferation. Furthermore, KLK7 has been suggested as a biomarker for certain diseases, making it a focal point in diagnostic research. To investigate its functions and develop potential therapeutic applications, researchers have focused on producing recombinant KLK7 protein. This involves using modern biotechnological methods to express and purify KLK7 in vitro, allowing for in-depth studies of its enzymatic activity, regulation, and involvement in pathophysiological processes. Understanding KLK7's mechanisms could lead to innovative treatments for skin disorders and provide insights into other diseases linked to its dysregulation, highlighting its importance in both basic research and clinical applications.